Novel Continuous Glucose Monitoring Metrics and Large-for-Gestational-Age Risk: An Exploratory Retrospective Cohort Study in Pregnancies with Type 1 Diabetes,Diabetes Technology & Therapeutics

当前位置： X-MOL 学术 › Diabetes Technol. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Novel Continuous Glucose Monitoring Metrics and Large-for-Gestational-Age Risk: An Exploratory Retrospective Cohort Study in Pregnancies with Type 1 Diabetes
Diabetes Technology & Therapeutics ( IF 5.4 ) Pub Date : 2022-01-05 , DOI: 10.1089/dia.2021.0194
Rafał Sibiak _{1,

2} , Paweł Gutaj ₁ , Beata Mrzewka-Rogacz ₁ , Urszula Mantaj ₁ , Ewa Wender-Ozegowska ₁

Affiliation

Background: Continuous glucose monitoring (CGM) improves pregnancy outcomes in patients with type 1 diabetes (T1D). We aimed to assess the between-group differences in glycated hemoglobin (HbA1c) and the incidence of large-for-gestational-age (LGA) neonates in CGM and glucometer users and analyze the potential association of novel CGM metrics with LGA risk in T1D pregnancies.

中文翻译：

新的连续血糖监测指标和大于胎龄儿的风险：1 型糖尿病妊娠的探索性回顾性队列研究

背景：持续血糖监测 (CGM) 可改善 1 型糖尿病 (T1D) 患者的妊娠结局。我们旨在评估 CGM 和血糖仪使用者中糖化血红蛋白 (HbA1c) 的组间差异和大于胎龄儿 (LGA) 的发生率，并分析新的 CGM 指标与 T1D 妊娠中 LGA 风险的潜在关联.

更新日期：2022-01-06

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>